{"@id":"https://bioecon.ru/technology/ai-protocol-drafting-trial-optimization/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://cn.bioecon.ru/technology/ai-protocol-drafting-trial-optimization/","json":"https://cn.bioecon.ru/api/v1/technology/ai-protocol-drafting-trial-optimization/index.json"},"id":"ai-protocol-drafting-trial-optimization","industries":["digital-robotics","bio-ai","pharma","services"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/digital-robotics/","https://bioecon.ru/industries/bio-ai/","https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/services/"],"suppliers":["https://bioecon.ru/companies/ekosistem-engineering/","https://bioecon.ru/companies/cell-agritech/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/archireef/","https://bioecon.ru/companies/pivot-bio/","https://bioecon.ru/companies/the-quinta-group/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/bioinfood/","https://bioecon.ru/companies/shandong-sanyuan-biotechnology-co-ltd/"]},"maturity":8,"name":"生成式AI辅助临床试验方案科学设计与历史方案大数据智能优化副驾驶系统","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"synbio-enabling","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"万例历史临床试验知识图谱智能检索与对标分析"},{"n":2,"title":"符合TransCelerate国际标准的方案全要素结构化起草"},{"n":3,"title":"入排标准可行性与受试者可招募性负担量化打分"},{"n":4,"title":"访视检查日程表（SoA）受试者遵从度与负担削减优化"}],"summary":"依托经过上万篇历史临床试验完整方案、FDA/EMA最新监管指导原则及罕见病真实世界数据深度微调的垂直领域生成式AI大语言模型。系统作为方案设计者的智能副驾驶，不仅能在数分钟内生成结构化的高质量试验方案初稿、精简严谨的受试者入组与排除标准（I/E criteria），更能前瞻性识别复杂访视评估日程中的过度检查负荷，将后期昂贵的方案重大修订率（Amendments）降低50%以上。","url":"/technology/ai-protocol-drafting-trial-optimization/","verified":"2026-11-22"}